Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancers.

Westwood JA, Matthews GM, Shortt J, Faulkner D, Pegram HJ, Duong CP, Chesi M, Bergsagel PL, Sharp LL, Huhn RD, Darcy PK, Johnstone RW, Kershaw MH.

Leuk Res. 2014 Aug;38(8):948-54. doi: 10.1016/j.leukres.2014.05.010. Epub 2014 Jun 2.

PMID:
24934848
2.

PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody.

Escuin-Ordinas H, Elliott MW, Atefi M, Lee M, Ng C, Wei L, Comin-Anduix B, Montecino-Rodriguez E, Avramis E, Radu C, Sharp LL, Ribas A.

J Immunother Cancer. 2013 Aug 27;1:14. doi: 10.1186/2051-1426-1-14. eCollection 2013.

3.

Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies.

Verbrugge I, Hagekyriakou J, Sharp LL, Galli M, West A, McLaughlin NM, Duret H, Yagita H, Johnstone RW, Smyth MJ, Haynes NM.

Cancer Res. 2012 Jul 1;72(13):3163-74. doi: 10.1158/0008-5472.CAN-12-0210. Epub 2012 May 8.

4.

Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity.

Fisher TS, Kamperschroer C, Oliphant T, Love VA, Lira PD, Doyonnas R, Bergqvist S, Baxi SM, Rohner A, Shen AC, Huang C, Sokolowski SA, Sharp LL.

Cancer Immunol Immunother. 2012 Oct;61(10):1721-33. Epub 2012 Mar 11.

PMID:
22406983
5.

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.

Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, Huhn RD, Song W, Li D, Sharp LL, Torigian DA, O'Dwyer PJ, Vonderheide RH.

Science. 2011 Mar 25;331(6024):1612-6. doi: 10.1126/science.1198443.

6.

Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk.

Broussard C, Fleischacker C, Horai R, Chetana M, Venegas AM, Sharp LL, Hedrick SM, Fowlkes BJ, Schwartzberg PL.

Immunity. 2006 Jul;25(1):93-104. Erratum in: Immunity. 2006 Nov;25(5):849. Fleischecker, Christine [corrected to Fleischacker, Christine].

7.

Active Ca2+/calmodulin-dependent protein kinase II gamma B impairs positive selection of T cells by modulating TCR signaling.

McGargill MA, Sharp LL, Bui JD, Hedrick SM, Calbo S.

J Immunol. 2005 Jul 15;175(2):656-64.

8.

Gammadelta T cell-induced hyaluronan production by epithelial cells regulates inflammation.

Jameson JM, Cauvi G, Sharp LL, Witherden DA, Havran WL.

J Exp Med. 2005 Apr 18;201(8):1269-79.

9.

Dendritic epidermal T-cell activation.

Sharp LL, Jameson JM, Witherden DA, Komori HK, Havran WL.

Crit Rev Immunol. 2005;25(1):1-18. Review.

PMID:
15833080
10.

Dendritic epidermal T cells regulate skin homeostasis through local production of insulin-like growth factor 1.

Sharp LL, Jameson JM, Cauvi G, Havran WL.

Nat Immunol. 2005 Jan;6(1):73-9. Epub 2004 Dec 12.

PMID:
15592472
11.

Regulation of skin cell homeostasis by gamma delta T cells.

Jameson JM, Sharp LL, Witherden DA, Havran WL.

Front Biosci. 2004 Sep 1;9:2640-51. Review.

PMID:
15358587
12.
14.

T-cell fate.

Hedrick SM, Sharp LL.

Immunol Rev. 1998 Oct;165:95-110. Review.

PMID:
9850855
15.

Function of protonatable residues in the flagellar motor of Escherichia coli: a critical role for Asp 32 of MotB.

Zhou J, Sharp LL, Tang HL, Lloyd SA, Billings S, Braun TF, Blair DF.

J Bacteriol. 1998 May;180(10):2729-35.

16.

The influence of the MAPK pathway on T cell lineage commitment.

Sharp LL, Schwarz DA, Bott CM, Marshall CJ, Hedrick SM.

Immunity. 1997 Nov;7(5):609-18.

17.

E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas.

Bain G, Engel I, Robanus Maandag EC, te Riele HP, Voland JR, Sharp LL, Chun J, Huey B, Pinkel D, Murre C.

Mol Cell Biol. 1997 Aug;17(8):4782-91.

18.

Features of MotA proton channel structure revealed by tryptophan-scanning mutagenesis.

Sharp LL, Zhou J, Blair DF.

Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7946-50.

19.

Supplemental Content

Loading ...
Support Center